Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Grace Therapeutics, Inc
GRCE
Healthcare
Biotechnology
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel...
, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GRCE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
(101)
•••
3burtc
X
Comment by
3burtc
on Aug 31, 2020 8:23am
RE:RE:Whenever Boozehound bashes ACST
It's finished!
(13)
•••
LowtoHigh
X
Comment by
LowtoHigh
on Aug 31, 2020 8:06am
RE:Whenever Boozehound bashes ACST
Run up based on what exactly? Does this company even have other products / trials out there? Isn't their entire company propped up on Capre? It may take months until there back to Friday numbers
...more
(101)
•••
3burtc
X
Comment by
3burtc
on Aug 31, 2020 7:55am
RE:Francine
Stick a fork in it........
(3)
•••
boozehound3
X
Post by
boozehound3
on Aug 31, 2020 7:44am
Francine
Hopefully you sold last week when you got the news
(3)
•••
boozehound3
X
Comment by
boozehound3
on Aug 31, 2020 7:21am
RE:RE:RE:Whenever Boozehound bashes ACST
Should have listened and had a drink with me
(3)
•••
boozehound3
X
Post by
boozehound3
on Aug 31, 2020 7:17am
Oh no
Old boozy right all along.
(13)
•••
LowtoHigh
X
Comment by
LowtoHigh
on Aug 30, 2020 2:34pm
RE:Monday Success
I have a really small position in this but wanted to see how Monday would perform. GLTA.
(13)
•••
Danny1082Man
X
Post by
Danny1082Man
on Aug 28, 2020 6:26pm
Monday Success
Irregular after hour action with over 500k share bought at prices 9 cents (usd) from today's low. You know Acasti has data in hand right now. Analyzing and preparing PR for Monday. GLTA
(13)
•••
Danny1082Man
X
Comment by
Danny1082Man
on Aug 28, 2020 10:55am
RE:RE:No posts since the 25th? Odd.
I'm here and still holding. The placebo problems should regress back to the mean. We already know CaPre works.
(13)
•••
LowtoHigh
X
Comment by
LowtoHigh
on Aug 27, 2020 10:40pm
RE:No posts since the 25th? Odd.
Im here...waiting for the results of Capre.
(7)
•••
RedMonk
X
Post by
RedMonk
on Aug 27, 2020 12:20pm
No posts since the 25th? Odd.
Just checking to see if its still working
(3)
•••
boozehound3
X
Comment by
boozehound3
on Aug 26, 2020 3:46pm
RE:Whoever has listened to Francine
Ha ha
(77)
•••
Rosmorduc
X
Comment by
Rosmorduc
on Aug 25, 2020 7:16pm
RE:RE:Whenever Boozehound bashes ACST
Go have another booze on me. That's all you're good for anyway.
(3)
•••
boozehound3
X
Comment by
boozehound3
on Aug 25, 2020 5:16pm
RE:Whenever Boozehound bashes ACST
You are bi polar. Look at your old poses bashing this thing when you missed the run
(77)
•••
Rosmorduc
X
Post by
Rosmorduc
on Aug 25, 2020 4:21pm
Whenever Boozehound bashes ACST
Stock has run up a few days later. Never fails! Keep up the bad job Boozehound. Bought more today because of your exceptional track record of failed predictions.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Creating a Non-Opioid Solution for Chronic Pain Management